CCP
SRNE

Corient Capital Partners’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Corient Capital Partners’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2022
Q3 		$30K Hold
14,913
– – ﹤0.01% 663
2022
Q2 		$30K Buy
+14,913
New +$30K ﹤0.01% 678